RECRUITING

Adaptation and Initial Evaluation of Transdiagnostic CBT for Anxious and Depressed Smokers

Description

This study will look at the effectiveness of a new treatment protocol for anxious and depressed smokers. Participants with clinically significant anxiety or depression will receive either the standard smoking cessation treatment or the Unified Protocol for Smoking Cessation Treatment. This study will demonstrate that a single treatment protocol can effectively address both smoking and the complex emotional comorbidities that are widespread in smokers will provide a novel, impactful, and highly disseminable treatment option missing from today's smoking cessation arsenal.

Study Overview

Study Details

Study overview

This study will look at the effectiveness of a new treatment protocol for anxious and depressed smokers. Participants with clinically significant anxiety or depression will receive either the standard smoking cessation treatment or the Unified Protocol for Smoking Cessation Treatment. This study will demonstrate that a single treatment protocol can effectively address both smoking and the complex emotional comorbidities that are widespread in smokers will provide a novel, impactful, and highly disseminable treatment option missing from today's smoking cessation arsenal.

Adaptation and Initial Evaluation of Transdiagnostic CBT for Anxious and Depressed Smokers

Adaptation and Initial Evaluation of Transdiagnostic CBT for Anxious and Depressed Smokers

Condition
Smoking Cessation
Intervention / Treatment

-

Contacts and Locations

Houston

University of Houston, Houston, Texas, United States, 77204

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 65 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    University of Houston,

    Michael Zvolensky, Ph.D., PRINCIPAL_INVESTIGATOR, University of Houston

    Matthew Gallagher, Ph.D., STUDY_DIRECTOR, University of Houston

    Study Record Dates

    2024-02